These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 982358)

  • 21. Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.
    MacIntyre DE; Salzman EW; Gordon JL
    Biochem J; 1978 Sep; 174(3):921-9. PubMed ID: 215124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
    Hawiger J; Parkinson S; Timmons S
    Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G; Cerletti C; Castagnoli MN; Bertelé V; de Gaetano G
    Biochem Pharmacol; 1985 Feb; 34(3):307-10. PubMed ID: 3918536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential inhibition of prostacyclin production and platelet aggregation by aspirin in humans.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Adv Prostaglandin Thromboxane Res; 1980; 6():317-20. PubMed ID: 6992529
    [No Abstract]   [Full Text] [Related]  

  • 25. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
    Smith JB; Ingerman CM; Silver MJ
    J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of specific estrogens on prostaglandin synthesis in aorta and thrombocytes of female pigeons.
    Subbiah MT; Deitemeyer D; Yunker R; Gallon L
    Proc Soc Exp Biol Med; 1981 Feb; 166(2):300-4. PubMed ID: 7208490
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 28. Mitoxantrone and bisantrene inhibition of platelet aggregation and prostaglandin E2 production in vitro.
    Frank P; Novak RF
    Biochem Pharmacol; 1985 Oct; 34(19):3609-14. PubMed ID: 3863620
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of minoxidil on platelet function and the synthesis of prostaglandins in platelets.
    O'Barr TP; Swanson EW; Fitzpatrick JE; Corby DG
    J Lab Clin Med; 1989 Nov; 114(5):575-8. PubMed ID: 2553835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboxane A2 and the endoperoxides mediate canine platelet activation.
    Harris RH; Nichols R; Schmeling JW; Ramwell PW
    Thromb Res; 1981 Sep; 23(6):521-32. PubMed ID: 6798707
    [No Abstract]   [Full Text] [Related]  

  • 31. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion.
    Weiss HJ; Willis AL; Kuhn D; Brand H
    Br J Haematol; 1976 Feb; 32(2):257-72. PubMed ID: 1247498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydrocortisone, platelet aggregation and platelet prostaglandin metabolism.
    Jørgensen KA; Stoffersen E
    Scand J Haematol; 1980 Nov; 25(5):445-7. PubMed ID: 7221479
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of prostaglandin F2a on aggregation of canine platelets.
    Longenecker GL
    Thromb Res; 1980 May 1-15; 18(3-4):369-74. PubMed ID: 7414536
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased arachidonate in lipids after administration to man: effects on prostaglandin biosynthesis.
    Seyberth HW; Oelz O; Kennedy T; Sweetman BJ; Danon A; Frölich JC; Heimberg M; Oates JA
    Clin Pharmacol Ther; 1975 Nov; 18(5 Pt 1):521-9. PubMed ID: 1102230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the platelet release reaction and platelet prostagland in synthesis by furosemide.
    Ingerman CM; Smith JB; Silver MJ
    Thromb Res; 1976 Mar; 8(3):417-9. PubMed ID: 1265713
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction in adenosine diphosphate-induced platelet aggregation by infusion of norepinephrine into dogs.
    Morin RJ; Burkart W; Garner D; Laks M
    Pharmacol Res Commun; 1978 Oct; 10(9):831-7. PubMed ID: 724741
    [No Abstract]   [Full Text] [Related]  

  • 38. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

  • 39. Discrimination between platelet prostaglandin receptors with a specific antagonist of bisenoic prostaglandins.
    MacIntyre DE; Gordon JL
    Thromb Res; 1977 Dec; 11(6):705-13. PubMed ID: 203057
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
    Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
    J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.